Ipamorelin-5mg

Ipamorelin

is a highly selective, synthetic pentapeptide growth hormone secretagogue (GHS) that acts as a potent ghrelin receptor agonist. It is recognized as one of the most selective growth hormone (GH) releasing peptides available. It binds directly to the growth hormone secretagogue receptor (GHS-R) in both the brain and the pituitary gland. Unlike older generations of secretagogues, Ipamorelin triggers a highly targeted release of GH without causing parallel spikes in other pituitary hormones, making it an essential tool for clean metabolic and endocrine research.

Key Features & Characteristics

• Mechanism of Action: Targets and activates the GHS-R on pituitary somatotropes to induce a natural, pulsatile wave of endogenous growth hormone.
• Extreme Selectivity: Unlike GHRP-2 or GHRP-6, it does not elevate cortisol, prolactin, or ACTH levels during experimental observation.
• Minimal Appetite Stimulation: Does not trigger the intense hyperphagia or severe hunger responses frequently associated with first-generation ghrelin mimetics.
• Physical Form: Produced via high-fidelity synthesis and supplied as a stable, ultra-pure white lyophilized powder ready for precise fluid reconstitution.

Primary Research Applications

• Somatotropic Pathway Mapping: Extensively studied in animal models to observe pure growth hormone release dynamics without interference from secondary hormonal cascades.
• Gastrointestinal Motility: Investigated for its ability to accelerate gastric emptying and reverse postoperative ileus (paralyzed bowel symptoms) in animal models.
• Anabolic & Connective Tissue Repair: Evaluated for its downstream role in elevating systemic Insulin-like Growth Factor 1 (IGF-1) to study bone density growth, collagen synthesis, and lean muscle preservation.

For Research Use Only. Not for human consumption, therapeutic, or diagnostic use.